Trial Information
CRESTONE: A Phase 2 Study of Seribantumab in Adult Patients with Neuregulin-1 (NRG1) Fusion Positive Locally Advanced or Metastatic Solid Tumors (ELVCAP-001-01)
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at
877-664-7724